ALK and lung carcinoma: METex14 skipping mutation is considered to be an independent lung cancer driver, which is usually mutually exclusive with other lung cancer driver genes such as EGFR, ALK and ROS1, and is also associated with poor prognosis of lung cancer, including sarcomatoid cancer (19).